Psychiatry and Neurology, Neurology · Macon, GA
NPI
1902846850
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
389 Mulberry St, Suite 200
Macon, GA, 31201
Phone (478) 743-9123
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
3,195 services
Medicare patients, 2024
447
Average age 74
Drug cost, 2024
$2.7M
5,119 prescriptions
Company payments, 2025
$56.94
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christina L Mayville was code 99213 (office e&m - established), 299 times for 232 patients. In total Christina L Mayville billed 3,195 services in 30 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 299 | 232 | $55.59 | $17K |
| A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | Office | 273 | 19 | $1.11 | $303 |
| 99214 Office E&M - Established | Office | 216 | 170 | $80.36 | $17K |
| 99204 Office E&M - New | Office | 67 | 67 | $105.10 | $7,041 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 60 | 56 | $11.27 | $676 |
| 95886 Electrical Nerve Conductivity | Office | 48 | 23 | $66.19 | $3,177 |
| 70551 MRI/MRA - Head and Neck | Office | 45 | 45 | $81.09 | $3,649 |
| 99215 Office E&M - Established | Office | 32 | 30 | $108.33 | $3,467 |
| 99212 Office E&M - Established | Office | 24 | 23 | $36.64 | $879 |
| 99205 Office E&M - New | Office | 19 | 19 | $150.63 | $2,862 |
| 70553 MRI/MRA - Head and Neck | Office | 18 | 17 | $126.01 | $2,268 |
| 99203 Office E&M - New | Office | 16 | 16 | $74.75 | $1,196 |
| 95816 Neurologic | Office | 11 | 11 | $265.60 | $2,922 |
By year: 2022 $96K for 4,668 services; 2023 $80K for 3,259 services; 2024 $80K for 3,195 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christina L Mayville prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 460 prescriptions and refills. In total Christina L Mayville wrote 5,119 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 460 | 857 | 96 | $18K |
| Memantine Hcl Generic | 351 | 643 | 89 | $9,263 |
| Donepezil Hcl Generic | 349 | 704 | 86 | $4,349 |
| Levetiracetam Generic | 328 | 624 | 67 | $10K |
| Gabapentin Generic | 229 | 390 | 57 | $5,105 |
| Clonazepam Generic | 227 | 273 | 43 | $1,380 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 159 | 159 | Under 11 | $1.3M |
| Primidone Generic | 159 | 366 | 40 | $6,096 |
| Quetiapine Fumarate Generic | 142 | 206 | 31 | $1,699 |
| Citalopram Hbr Citalopram Hydrobromide | 124 | 220 | 25 | $412 |
| Tizanidine Hcl Generic | 119 | 229 | 36 | $2,913 |
| Topiramate Generic | 110 | 258 | 33 | $1,823 |
| Lamotrigine Generic | 93 | 169 | 20 | $1,057 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 90 | 172 | 18 | $1,858 |
| Aimovig Autoinjector Erenumab-Aooe | 83 | 100 | 12 | $76K |
Brand drugs: 545 claims; generic drugs: 4,538 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christina L Mayville $56.94 ($56.94 in general payments such as food, travel and fees) from 1 company. The largest payer was SK Life Science, Inc. with $56.94.
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 1 | $56.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.